Researchers at the Pasteur Institute in Tunisia have been conducting a study since 2023 to identify genetic factors that may contribute to cognitive decline in diabetic patients and their progression to Alzheimer's disease. The study aims to develop an early detection method for individuals most at risk and improve their care. According to Professor of Genetics, Rim Kafi, recent studies suggest that approximately 70% of diabetics are at risk of cognitive decline, increasing their likelihood of developing Alzheimer's.
The research team at the Pasteur Institute has been working to understand the factors that make some diabetic patients more susceptible to cognitive decline and Alzheimer's disease, with a focus on genetic factors associated with the disease. The team is currently conducting a study involving 100 samples from diabetic patients to identify scientific indicators that can help understand the relationship between the two diseases and detect individuals most at risk of developing Alzheimer's.
The study aims to develop a blood test and genetic screening that can be used to determine the likelihood of diabetics developing Alzheimer's disease. This would enable early intervention and potentially prevent or slow disease progression. According to experts, early detection of individuals at risk can facilitate prevention and monitoring of their health in the early stages.
The research has significant implications for public health, as Alzheimer's disease is a major health concern in Tunisia. The study's findings are expected to be available in the coming years, and the researchers plan to expand the study to include a larger sample size. The development of an early detection method could lead to improved care and outcomes for diabetic patients at risk of developing Alzheimer's.
The study was presented at a scientific day organized by the City of Sciences in Tunis, in collaboration with the Alzheimer's Association in Tunisia. The event highlighted the importance of innovation, prevention, and accompaniment in addressing Alzheimer's disease. Experts emphasized that prevention and control of risk factors are crucial in reducing the risk of developing Alzheimer's.
The research team at the Pasteur Institute is working to advance the understanding of the relationship between diabetes and Alzheimer's disease. The study's findings have the potential to inform the development of new treatments and interventions for diabetic patients at risk of developing Alzheimer's. The researchers' work is an important step towards improving the health outcomes of individuals with diabetes.
The development of an early detection method for Alzheimer's disease in diabetics is a significant step towards improving public health in Tunisia. The study's findings are expected to contribute to the development of new strategies for preventing and managing Alzheimer's disease. The research team's work highlights the importance of continued investment in scientific research to address major health concerns.
Key points
- Researchers at the Pasteur Institute in Tunisia are developing a blood test to detect Alzheimer's disease in diabetics.
- The study aims to identify genetic factors that contribute to cognitive decline in diabetic patients and their progression to Alzheimer's disease.
- Early detection of individuals at risk can facilitate prevention and monitoring of their health in the early stages.
